期刊文献+

国产FDG模块自动化合成3’-脱氧-3’-[^(18)F]氟代胸苷 被引量:2

Automatic Synthesis of 3'-Deoxy-3'-^(18)F-fluorothymidine Using a Domestic FDG Module
在线阅读 下载PDF
导出
摘要 采用附接半制备HPLC的国产FDG模块自动化合成了3’-脱氧-3’-[18 F]氟代胸(腺嘧啶脱氧核)苷(18F-FLT)。将15mg 3-N-Boc-5’-O-二甲氧基三苯基-3’-O-nosyl-胸苷溶解在0.5mL DMSO中,使之与18F-在100℃反应5min,之后用1mol/L HCl于110℃下水解5min,用2mol/L NaOH中和;TLC法测得18F-FLT的标记率为67.5%(n=8),而HPLC测得的标记率为39.4%(n=6);产品经半制备HPLC分离纯化,最终产品的合成效率为21.2%(n=3,不衰减校正),包括半制备HPLC的分离纯化在内,总的合成时间为30min。产品的放化纯度大于99%,比活度大于740TBq/g(180PBq/mol)。产品在10%乙醇中,6h内未见分解。以上结果表明,国产FDG模块配合半制备HPLC,可以合成满足临床需求的18F-FLT。 3'-Deoxy-3'-fluorothymidine(18F-FLT) is a radiotracer for the imaging of tumor proliferation.A clinically applicable automatic system for the preparation of 18F-FLT was developed by modifying a domestic 18F-FDG synthesizer with semipreparative HPLC.Fifteen milligrams of 3-N-Boc-5'-O-dimethoxytrityl-3'-O-nosyl-thymidine were dissolved in 0.5 mL DMSO and reacted with dried 18F-fluoride at 100 ℃ for 5 min.The obtained material was hydrolyzed with 1 mol/L HCl at 110 ℃ for 5 min,and then neutralized with 2 mol/L NaOH before HPLC purification was performed.The desired radioactive fraction was collected after passing through a 0.22 m filter into a 30 mL vial as the final product.The 18F-FLT labelling yield was found to be 67.5%(n=8) by the radio-TLC method,and 39.4%(n=6) by the HPLC method.The yield as the final product for clinical use was 21.2%(n=3,not corrected for decay).The total preparation time,including the time for HPLC purification,was 30 min.The radiochemical purity of the final product was over 99%,and the specific activity was higher than 740 TBq/mg(180 PBq/mol).The final product was stable for more than 6 h in the 10% alcohol solution.This preparation system with semipreparative HPLC enables us to produce 18F-FLT with a stable yield for clinical use.
出处 《同位素》 CAS 2012年第1期15-20,共6页 Journal of Isotopes
基金 核能开发科技项目资助(2009-1228) 吴阶平医学基金资助(320.6750.08054)
关键词 18F-FLT 自动化合成 FDG模块 18F-FLT automatic synthesis FDG synthesizer
  • 相关文献

参考文献13

  • 1Clemens K,Gerhard G,Malik J,et al.Early assessment of therapy response in malignant lymphoma with the thymidine analogue 18F-FLT[J].Eur J Nucl Med and Mol Imag, 2007, 34: 1 175-1 782.
  • 2Bianca MK,Johannes B,Jasper TF,et al.Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice:comparison of 2 '-deoxy-2,-[-18 F] fluoro-D-glucose (FDG) and 3 '[18 F] fluoro-3 '-deoxythymidine FLT[J]. Mol Imag Biol,2007,9:340-347.
  • 3Oh SJ,Chi DY,Mosdzianowski C,et al.Fully automated synthesis of[18 F] fluoromisonidazole using a conventional[18 F] FDG module[J].Nucl Med Biol,2005,32(8):899-905.
  • 4Marik J,Sutcliffe JL.Fully automated preparation of n.c.a.4-[18F] fluorobenzoic acid and N-succinimidyl 4-[18F] fluorobenzoate using a siemens/CTI chemistry process control unit (CPCU)[J].Appl Radiat Isot,2007,65(2):199-203.
  • 5Oh SJ,Chi DY,Mosdzianowski C,et al.The automatic production of 16-alpha-[18F] fluoroestradiol using a conventional[18F] FDG module with a disposable cassette system[J]. Appl Radiat Isot,2007,65(6):676-681.
  • 6张锦明,田嘉禾,姚树林,刘晓飞,刘振峰,郭喆.FDG模块自动化合成2-^(18)F-乙酸盐及其临床前研究[J].中华核医学杂志,2007,27(4):215-217. 被引量:12
  • 7Kryza D,Tadino V,Filannino MA,et al.Fully automated[18 F] fluorocholine synthesis in the tracerlab MX FDG coincidence synthesizer[J].Nucl Med Biol,2008,35(2):255-260.
  • 8Oh SJ,Mosdzianows C,de Yoon Chi DY,et al.Fully automated synthesis system of 3-deoxy-3-[18F] fluorothymidine[J].Nucl Med Biol,2004,31:803-809.
  • 9张锦明,田嘉禾,刘长滨,刘健,罗志刚.3’-脱氧-3’-[^(18)F]氟代胸腺苷自动化合成效率的影响因素[J].同位素,2009,22(3):160-164. 被引量:5
  • 10Ma Y,Huang BX,Channing MA,et al.Quantification of Kryptofix 2.2.2 in 2-[18 F] FDG and other radiopharmaceuticals by LC/MS/MS[J]. Nucl Med Biol,2002,29:125-129.

二级参考文献27

  • 1傅喆,滕宝,吴战宏,李方,陈盛祖.半自动化制备多种氟标药物模块的初步探讨[J].同位素,2005,18(4):233-236. 被引量:2
  • 2唐刚华,唐小兰,王明芳,罗磊,甘满权.肿瘤显像剂^(18)F-氟代乙酸盐的自动化合成[J].核技术,2006,29(1):59-62. 被引量:9
  • 3辛军,李宏利,郭启勇,赵周社.采用离子液体作为相转移催化剂一步法合成^(18)F-FLT的方法研究[J].中国临床医学影像杂志,2007,18(5):348-350. 被引量:1
  • 4Been LB, Suurmeijer A, Connen D, et al. ^18F- FLT-PET in oncology: current status and opportunities[J]. Eur J Nucl Med Mol Imaging, 2004, 31:1 659-1 672.
  • 5Yun M, Jun Oh SJ, Ha HJ, et al. High radiochemical yield synthesis of 3'-deoxy-3' -[^18 F]-fluorothymidine using (5'-O-dimethoxytrityl-2'- deoxy-3'-O-nosyl-β-D-threo pentofuranosyl) thymine and its 3-N-BOC-protected analogue as a labeling precursor[J]. Nucl Med Biol, 200a, 30: 151-157.
  • 6Oh SJ, Mosdzianowsk C, Chi DY, et al. Fully automated synthesis system of 3'-deoxy-3'[^18F]fluorothymidine[J]. Nuel Med Biol, 2004, 31: 803-809.
  • 7Chirakal R, McCarry B, Lonergan M, et al. Basemediated decomposition of amannose triflate during the synthesis of 2-deoxy-2-18 F-fluoro-D-glucose[J]. Appl Radiat Isot , 1995, 46 (3): 149-155.
  • 8Suehiro M, Vallabhajosula S, Stanley J, et al. Investigation of the role of the base in the synthesis of [^18F]FLT[J]. Appl Radiat Isot, 2007, 65: 1 350-1 358.
  • 9张锦明,田嘉禾,于生民,等.可视化、双反应管氟-18多功能自动化合成模块:中国,200910119295.3[P].[2008-12-10].
  • 10Lee S J, Oh S J, Chi D Y, et al. Eur J Nucl Med Mol Imaging, 2007, 34:1406-1409.

共引文献16

同被引文献24

  • 1张锦明,田嘉禾,王武尚,刘伯里.在线制备^(11)C-Triflate-CH_3[J].同位素,2006,19(2):124-128. 被引量:21
  • 2Shreve PD, Anzai Y, Wahl RI. Pitfalls in oncologic diag- nosis with FDG PET imaging :physiologic and benign variants[J], tkadiographics, 1999,19:61-77.
  • 3Been LB, Suurmeijer AJH, Cobben DCP, et al. [18F]FLT- PET in oncology: current status and opportunities[J]. Eur J Nucl Med Mol Imaging,2004, 31:1659-1672.
  • 4Wilson IK, Chatterjee S, Wolf W. Synthesis of 3'-fluo- ro-3'-deoxythymidine and studies of its lSF radiolabeling, as a tracer for the noninvasive monitoring of the biodistri- bution of drugs against AIDS[J]. J Fluorine Chem, 1991, 55(3):283-289.
  • 5Mar SJ, Eisenbarth JA, Wagner-Utermann U, et al. A new precursor for the radiosynthesis of [lSF]FLT[J]. Nucl Med Biol,2002, 29:263-273.
  • 6Yun MY, Oh SJ, Ha HJ, et 01. High radiochemical yield synthesis of 3'-deoxy-3'-[lSF]fluorothymidine using pen- tofuranosyl)thymine and its 3-N-BOC-protected anal- ogne as a labeling precursor [J]. Nucl Med Biol, 2003, 30: 151-157.
  • 7Tang GH, Tang XL, Wen MF, et a/. A Facile and rapid automated synthesis of 3' -deoxy-3' -[lSF] fluorothymi- dine[J]. App1 Radiat Isot, 2010, 68:1734-1739.
  • 8Grierson JR., Shields AF. Radiosynthesis of 3'-deoxy-3' -[lSF]fluorothymidine: [SF] FLT for imaging of cellular proliferation in vivo[J]. Nucl Med Biol,2008, 27:143- 156.
  • 9Brichard L, Aighirhio FI. An ecient method for enhanc- ing the reactivity and flexibility of [lSF] fluoride towards nucleophilic substitution using tetraethylammonium bicar- bonate[J]. EurJ Org chem,2014:6145-6149.
  • 10Richarz I, Krapf P, Zarrad F, et al. Neither azeotropic drying, nor base nor other additives:a minimalist approach to *SF-labeling[J]. Org Biomol Chem,2014, 12:8094- 8099.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部